EMeRG
  • PRODUCTS
    • HOSPeTRACK
    • medRUPTER
    • medCIN
    • VOC REPORTS
  • MED-TECH INSIGHTS
    • ASEAN
    • AFRICA
    • MIDDLE EAST
    • LATIN AMERICA
    • SUBCONTINENT
  • MED-TECH RESEARCH
    • NPI RESEARCH
    • CIO ADVISORY
    • VALUE PROP RESEARCH
    • OUTCOMES RESEARCH
    • PRICING RESEARCH
    • GTM STRATEGY RESEARCH
    • CONFERENCE RESEARCH
  • CASE STUDIES
    • BY MEDICAL TECHNOLOGIES
    • BY GEOGRAPHIES
    • BY BUSINESS CHALLENGES
  • ABOUT EMeRG
    • WHY EMeRG
    • HISTORY & MISSION
    • MANAGEMENT
    • TEAM
    • OUR APPROACH
    • OUR REACH
    • CAREER AND CULTURE
  • CONTACT US
EMeRG
  • PRODUCTS
    • HOSPeTRACK
    • medRUPTER
    • medCIN
    • VOC REPORTS
  • MED-TECH INSIGHTS
    • ASEAN
    • AFRICA
    • MIDDLE EAST
    • LATIN AMERICA
    • SUBCONTINENT
  • MED-TECH RESEARCH
    • NPI RESEARCH
    • CIO ADVISORY
    • VALUE PROP RESEARCH
    • OUTCOMES RESEARCH
    • PRICING RESEARCH
    • GTM STRATEGY RESEARCH
    • CONFERENCE RESEARCH
  • CASE STUDIES
    • BY MEDICAL TECHNOLOGIES
    • BY GEOGRAPHIES
    • BY BUSINESS CHALLENGES
  • ABOUT EMeRG
    • WHY EMeRG
    • HISTORY & MISSION
    • MANAGEMENT
    • TEAM
    • OUR APPROACH
    • OUR REACH
    • CAREER AND CULTURE
  • CONTACT US
HomeBY MEDICAL TECHNOLOGIESDiabetes Management

Diabetes Management

  • New Product Introduction: Non-invasive solution for measuring HbA1c

    • October 10, 2016
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Diabetes Management, Ethnographic Research, Market Entry Assessment, NPI Research, Pricing Research, SUBCONTINENT
    No Comments
    Overview: Market for HbA1c Tests  The global market for Self monitoring blood glucose (SMBG) devices was valued at $11Bn in 2015 and is characterized by intense competition and low entry barriers for low-cost manufacturers. In India, the market for SMBG devices and strips was valued at about $98Mn in 2015.While the annual median expenditure on
    read more
  • Business Case Creation for a US-Based Novel Blood Glucose Monitoring Company

    • November 18, 2015
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY BUSINESS CHALLENGES, BY MEDICAL TECHNOLOGIES, Diabetes Management, Market Entry Assessment, NPI Research, Pricing Research
    No Comments
    “CGM with infusion pump is very expensive for patients to buy. In India, hardly a few patients have CGM -  let alone infusion pumps. Now with newer technology I hope cost comes down and more patients have access to continuous monitoring. In Metropolitan cities around 5 % of the diabetic population would buy SMBG monitors.
    read more
  • Assessing reimbursement and pricing strategies for medical consumables and insulin delivery systems

    • September 9, 2014
    • Posted by: Team EMeRG
    • Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diabetes Management, GTM Strategy, Medical consumables, Pricing Research
    No Comments
    Overview: Market for Insulin Delivery in India With >69Mn cases, diabetes represents significant disease burden in India. In Urban India, approximately 12% of adults live with diabetes, compared to only 7% in the United States and the United Kingdom. Indian insulin market is valued at over $230Mn with Novo Nordisk being the market leader. While rapid
    read more

RECOMMENDED ARTICLES

  • Managed Equipment Services – A sustainable model for public-private partnership in emerging markets?

  • Lessons from Africa – How Algeria is improving maternal care

  • How e-health technologies are helping improve healthcare access in Kenya

  • Privatization of select hospitals in Vietnam continue despite poor revenue realizations

  • Singapore’s grand shift away from hospital-centric healthcare delivery

  • Could fee hikes dampen the healthcare reforms in Vietnam?

Contact us at EMeRG for your med-tech business intelligence needs in emerging markets

contacts

EMeRG

EMeRG is an international med-tech research and advisory firm unravelling “unarticulated” customer insights for med-tech markets. Founded in late 2013, EMeRG is addressing the “innovation in isolation” paradox within medical technology markets


Sign up for latest med-tech insights in EMeRGing markets

Loading

© 2022 | Ethnographic Medical Research Pvt. Ltd.
Designed & Maintained By Webomindapps

NEWS AND ANNOUNCEMENTS

  • EMeRG's HospeTrack data quoted on All Africa Story
  • Team EMeRG is attending HIMSS 2020
  • Team EMeRG is attending RSNA 2019
  • EMeRG cited in Pertanika Science and Technology Journal
  • EMeRG partners with PwC and Philips to publish Horizon Scanning Thought Leadership
  • EMeRG is attending Arab Health - 2018
  • EMeRG is attending RSNA - Chicago, 2017
  • EMeRG's publication on Telemedicine in Bangladesh cited in IISTE
  • Fostering an ecosystem for Indian med-tech - EMeRG attends Philips Breakthrough Day #btday
  • Unique format that brought the entire value chain under one roof - EMeRG attends MTaI Med-tech Summit 2017
  • EMeRG - Key participant in APACMed PwC Digital Health Workshop in Singapore
  • EMeRG's report on Brazilian medical devices market now available with Research and Markets
  • EMeRG's Voice of Customer Report for Dialysis added to Research and Markets' offerings
  • EMeRG brings ethnography backed med-tech research to emerging markets

TWITTER FEEDS

Tweets by EMeRG_MedTech
  • PRODUCTS
    • HOSPeTRACK
    • medRUPTER
    • medCIN
    • VOC REPORTS
  • MED-TECH INSIGHTS
    • ASEAN
    • AFRICA
    • MIDDLE EAST
    • LATIN AMERICA
    • SUBCONTINENT
  • MED-TECH RESEARCH
    • NPI RESEARCH
    • CIO ADVISORY
    • VALUE PROP RESEARCH
    • OUTCOMES RESEARCH
    • PRICING RESEARCH
    • GTM STRATEGY RESEARCH
    • CONFERENCE RESEARCH
  • CASE STUDIES
    • BY MEDICAL TECHNOLOGIES
    • BY GEOGRAPHIES
    • BY BUSINESS CHALLENGES
  • ABOUT EMeRG
    • WHY EMeRG
    • HISTORY & MISSION
    • MANAGEMENT
    • TEAM
    • OUR APPROACH
    • OUR REACH
    • CAREER AND CULTURE
  • CONTACT US